Fred Rockwell

Investor Summit Q3 2022 Virtual Conference Aug 16-17. 75 Microcap and Small Cap companies. 200+ investors, 1-on-1 meetings and more. Register today: bit.ly/3zmM3UD #microcaps #investing #conference

Link to the on-demand webcast for RespireRx Pharmaceuticals Inc.: A Biopharmaceutical Company -- us06web.zoom.us/webinar/regist…

Highlights: -- Potential breakthrough products for treating disorders with unmet medical needs -- Broad and deep patent portfolio #investorsummit #q4 #respirerxpharmaceuticals #biotech #conference #invest

RespireRx Pharmaceuticals Inc.: A Biopharmaceutical Company Their primary mission is to develop innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling. Presenters: Jeff Margolis, Arnold Lippa Market cap: $1 million

Link to the on-demand webcast Predictive Oncology Inc : us06web.zoom.us/webinar/regist…

--With a 92% accuracy, PeDAL is validated to predict with higher confidence whether a cancer tumor sample will respond --They offer the ability to test the viability of a cell with its 3D tumor models.

@PredictiveOnc (NASDAQ: POAI) creates a paradigm shift in drug development. Their flagship solution pairs proprietary AI w world’s largest commercial biobank of more than 150,000 tumor samples covering more than 130 cancer types & has power to advance the making of cancer drugs.

Link to the on-demand webcast for @CingulateInc : us06web.zoom.us/webinar/regist… #cingulate #investorsummit #q4 #biotech #biotechcompany #investing

Presenters: Thomas Dalton Market cap: $13 million Highlights: - Using approved molecules, they can achieve the first true full active day dosing for ADHD - Their proprietary drug delivery technology applies 2 numerous large markets with suboptimal medication dosing delivery

@CingulateInc (NASDAQ: CING), is a biopharmaceutical company using proprietary PTR™ drug delivery platform technology to build & advance pipeline of next-generation pharmaceutical products, designed to improve the lives of patients suffering from frequently diagnosed conditions

ICYMI, check out the Biotech companies that made a Splash at the Investor Summit this year:

as well as Alzheimer's, and Lou Gehrig's disease. Link to on-demand broadcast: us06web.zoom.us/webinar/regist… #investorsummit #biotech #biotechcompanies #q4

Highlights: -Revenue from near-term sales of generic drugs & an in vitro diagnostic, w longer-term potential from a patented, alpha-Klotho gene therapy program. -Essential, life-saving medicines that are in short supply/are in development for use to treat diseases like cancer

ANEW MEDICAL, INC. (ANEW) It's a publicly listed biotechnology company committed to the development of diagnostics and therapies for the benefit of the world’s elderly population and the multiple age-related disorders from which they suffer. Market cap: $2 million

#investorsummit #biotech #biotechconpanies #q4

Predictive Oncology Inc. (NASDAQ: POAI) is creating a paradigm shift in drug development. The company’s flagship solution pairs proprietary AI with the world’s largest commercial biobank of more than 150,000 actual tumor samples covering more than 130 cancer types

Direct link to on-demand webcast: us06web.zoom.us/webinar/regist…